In response to the recent @NYTimes editorial on cannabis and as a committee member on the @theNASEM #cannabis and #cannabinoids report we did NOT conclude that cannabis causes schizophrenia.
What Advocates of Legalizing Pot Don’t Want You to Know
Ziva Cooper
581 posts
Ziva Cooper
@zivacooper
Pharmacologist focused on effects of cannabis / cannabinoids. Director of UCLA's Center for Cannabis and Cannabinoids @UCLACannabis
- Do women and men respond differently to cannabis? What factors contribute to these differences? The @UCLA Cannabis Research Initiative is going to find out! ucla.in/2O5sg3f @UCLASemelFriend
- #Cannabis decreases the opioid dose needed for pain relief. Our double-blind, placebo-controlled study now available online! nature.com/articles/s4138… @ICRS_Society
- Topical CBD now in Walgreens and CVS in select states. And we still need a 750 lb safe to store it in the lab.......Walgreens will sell CBD creams, patches and sprays in nearly 1,500 stores in select states. cnb.cx/2FEKMN6
- Replying to @zivacooperWe found 1) an #association between cannabis use and schizophrenia and 2) an #association between cannabis use and IMPROVED cognitive outcomes in individuals with psychotic disorders (not mentioned in the editorial).
- Replying to @zivacooperWe also now know that under placebo-controlled conditions, #cannabidiol (#CBD) improves outcomes in patients with schizophrenia when given as an adjunct med, showing that cannabinoids (not necessarily cannabis) improve symptoms. ncbi.nlm.nih.gov/pubmed/29241357
- The @UCLA Cannabis Research Initiative will be base camp for interdisciplinary cannabis and cannabinoid research from molecular pharmacology to public policy. Research Director Q&A:The newly named director of UCLA Cannabis Research Initiative wants to study societal impacts of cannabis. Here's a Q&A: ucla.in/2Gil7tD
- Replying to @zivacooperDownload the @theNASEM report to learn more about the over 100 #associations between #cannabis, #cannabinoids, and #health outcomes. nationalacademies.org/hmd/Reports/20…
- Big news... and it only took 5 years to get here! Hope it will take less than 5 years for this decision to have a + impact on research... DEA Finally Ready To End Federal Marijuana Research Monopoly, Agency Notifies Grower Applicants | Marijuana Moment
- Replying to @zivacooperSince the report, we now know that genetic risk for schizophrenia predicts cannabis use, shedding some light on the potential direction of the association between cannabis use and schizophrenia.
- Huge congratulations to @canna_brain on receiving the @ICRS_Society Young Investigators Award 👏🏼 👏🏼 👏🏼! Looking forward to his talk on cannabinoids, stress, and anxiety #ICRS19
- Dose and cannabis experience are really important variables to consider when assessing CBD's effects on THC! Lots of interesting findings in this new pub: A RCT of vaporized #THC and #CBD alone and in combination. ncbi.nlm.nih.gov/pubmed/30661105
- Interested in cannabis / cannabinoid research? We're hiring postdoctoral fellows to join the UCLA Cannabis Research Initiative team. Please spread the word! @ICRS_Society @ccictweeter @CPDD19 uclahealth.org/cannabis/
- Very excited to be joining the @npp_journal team as Associate Editor - many thanks for the warm welcome from @ACNPorg and the twitter community!Please join us in welcoming Dr. Ziva Cooper @zivacooper to @npp_journal leadership as an Associate Editor beginning this September. Ziva is the Director of the Center for Cannabis and Cannabinoids at the University of California at Los Angeles (UCLA),
